Pegylated Liposomal Doxorubicin Combined With Anlotinib for Neoadjuvant Treatment of Soft Tissue Sarcoma
Clinical trial NCT04765228 · UNKNOWN
Trial details
- NCT number
- NCT04765228
- Sponsor
- Yong Chen
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-01
- Primary completion
- 2022-12-31
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.